Real world effectiveness and satisfaction with secukinumab in the treatment of patients with psoriatic arthritis: a population survey in five European countries-Reference-Cited by-同舟云学术

Real world effectiveness and satisfaction with secukinumab in the treatment of patients with psoriatic arthritis: a population survey in five European countries

Published:2021-07-23 Issue:10 Volume:37 Page:1845-1853
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Conaghan Philip G.¹^ORCID,Keininger Dorothy L.²,Holdsworth Elizabeth A.³^ORCID,Booth Nicola³^ORCID,Modi Niraj N.⁴^ORCID,Tian Haijun⁵,Kiltz Uta⁶⁷

Affiliation:

1. Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom

2. Novartis Pharma AG, Basel, Switzerland

3. Adelphi Real World, Bollington, United Kingdom

4. Novartis Healthcare Pvt. Ltd., Hyderabad, India

5. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

6. Rheumazentrum Ruhrgebiet, Herne, Germany

7. Ruhr Universität, Bochum, Germany

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1954500

Reference39 articles.

1. Early Psoriatic Arthritis

2. The Epidemiology of Psoriatic Arthritis

3. Comorbidities in Psoriatic Arthritis

4. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐World Treatment Patterns, Clinical Outcomes, and Symptom Burden in Patients With Psoriatic Arthritis Prescribed Ixekizumab in the United States;ACR Open Rheumatology;2024-05-05

2. Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study;Advances in Therapy;2023-10-07

3. What’s new and what’s next for biological and targeted synthetic treatments in psoriatic arthritis?;Expert Opinion on Biological Therapy;2022-12-02